Octreotide 500micrograms/1ml solution for injection ampoules
BNF presentation 0803043N0AAACAC within chapter Malignant Disease and Immunosuppression. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
0803043N0AAACAC
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
227
NHS spend (£)
£83,141.74
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 23 |
| December 2024 | 10 |
| November 2024 | 24 |
| October 2024 | 27 |
| July 2024 | 20 |
| May 2024 | 3 |
| July 2021 | 23 |
| June 2021 | 10 |
| December 2020 | 39 |
| November 2020 | 48 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
|
The Ivy Medical Group
ODS C84646
|
4 | 52R - NOTTINGHAM AND NOTTINGHAMSHIRE ICB |
| Unknown pharmacy | 4 | No data available |